Contents

Dihydromethysticin

Dihydromethysticin

Names
IUPAC name (2S)-2-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-2,3-dihydropyran-6-one
Identifiers
CAS Number	19902-91-1 Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL1510786 N
ChemSpider	200147 N
MeSH	C107882
PubChem CID	88308
UNII	FZ66MQ73GS Y
CompTox Dashboard (EPA)	DTXSID601314143
InChI InChI=1S/C15H16O5/c1-17-12-7-11(20-15(16)8-12)4-2-10-3-5-13-14(6-10)19-9-18-13/h3,5-6,8,11H,2,4,7,9H2,1H3 Key: RSIWXFIBHXYNFM-UHFFFAOYSA-N
SMILES COC1=CC(=O)OC(C1)CCC2=CC3=C(C=C2)OCO3
Properties
Chemical formula	C15H16O5
Molar mass	276.28 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

Chemical compound

Dihydromethysticin is one of the six major kavalactones found in the kava plant.^[1]

Pharmacology[edit]

Dihydromethysticin has marked activity on the induction of CYP3A23, as does the related chemical desmethoxyyangonin.^[2]

Both dihydromethysticin and methysticin induce the hepatic enzyme CYP1A1, which increases the amount of the very highly carcinogenic benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide in the body (via the metabolism of benzo[a]pyrene) and may be responsible for some of the toxic effects associated with kava consumption.^{[citation needed]}

In vitro, dihydromethysticin possesses analgesic, anticonvulsant, and anxiolytic effects.^[3] It has been found to act as a GABA_A receptor positive allosteric modulator and as an reversible inhibitorofmonoamine oxidase B.^[4][5]

References[edit]

External links[edit]

• Media related to Dihydromethysticin at Wikimedia Commons